5380W-13 Eli Lilly NAION

Eli Lilly NAION

Type of Study
Neuroscience - Neuro-Ophthalmology
Short Description
This is an observational study to evaluate the possible association between the use of PDE5 inhibitors and the risk of acute NAION (non-arteritic ischemic optic neuropathy) in adult male subjects.
Status
Open
Principal Investigator
Steven Hamilton, MD
Eligibility Notes
Inclusion:
  1. Adult Male subjects at least 18 years of age
  2. Experienced abrupt vision loss in one eye and presented for an initial visit within 45 days of symptom onset.
Exclusion:
  1. Previous history of NAION
  2. History of glaucoma
Contact Name
Caryl Tongco and Lauren Lennox
Phone
206-215-3565
Alternate Phone
206-320-4355
Email
caryl.tongco@swedish.org
Alternate Email
lauren.lennox@swedish.org